Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis

To compare the effects of 1 year of treatment with trimethoprim-sulfamethoxazole (TMP-SMZ) vs placebo in reducing the risk of recurrence of toxoplasmic retinochoroiditis during a 6-year follow-up period. Randomized, double-masked clinical trial. This cohort included 141 subjects recruited in Campina...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of ophthalmology 2020-05, Vol.213, p.195-202
Hauptverfasser:	Fernandes Felix, João Paulo, Cavalcanti Lira, Rodrigo Pessoa, Grupenmacher, Alex Treiger, Assis Filho, Hermano Lucio Gomes de, Cosimo, Alexandre Brito, Nascimento, Mauricio Abujamra, Leite Arieta, Carlos Eduardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Clinical trials Patient compliance Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!